Devana Solutions Welcomes Michael Bonavilla as Executive Director, Strategic Partnerships

Michael-BonavillaDevana Solutions is pleased to welcome Michael Bonavilla to our transformative cloud-SaaS company as Executive Director, Strategic Partnerships.

Michael comes to Devana Solutions after working with Bio-Optronics since 2007, where he helped launch the Clinical Conductor Clinical Trial Management System (CTMS). Over the last 15 years, including since 2021 when Bio-Optronics was acquired by Advarra, Michael helped expand the system to over 450 research organization clients to help streamline their business. Michael’s focus is working with clinical research sites of all types across the industry – identifying which technology solutions best fit their unique needs.

“I’ve had the pleasure to be part of the overall maturity of the clinical trial management solution market and have helped introduce many new solutions over the years,” says Michael. “I look forward to the opportunity to work with Devana Solutions and bridging the gap to now offer these same organizations a solution that compliments the CTMS and fills the critical need for business development, trial startup automation, metrics capture, and connectivity activity for the clinical research industry.”

As Executive Director, Strategic Partnerships, Michael will play a vital and highly visible role in Devana Solution’s outreach, education, and sales process. He will use his ample experience in the clinical trials and research industry to consult, educate, and ‘connect the dots’ between Devana’s solution and the needs of our prospective customers.

“Michael is someone I have long respected in the industry, and I was thrilled when he reached out about joining Devana,” explains Devana Solutions CEO Barry Lake. “If you had asked me to pick the top clinical trials technology business development professionals, Michael Bonavilla was at the top of my list.”

Devana Solutions is excited to have Michael join our growing team. With this latest addition, our company is more focused than ever and in the best position to serve our valued partner-clients.

Devana Solutions Welcomes Alex Schneider as Head of Product

Alex SchneiderDevana Solutions is excited to welcome Alex Schneider as Head of Product.

Alex comes to Devana Solutions with over 13 years of experience in user experience research and design, competition intelligence, and product management. Alex joins us from Westat, where he spent over five years, most recently as Head of UX.

Alex has spent his career architecting and delivering innovative, intuitive solutions to hundreds of thousands of researchers, participants, and people across the globe. A staunch advocate for users of all kinds, he works with executives and clients to understand and translate problems and needs into actionable, efficient and effective experiences.

As Head of Product, Alex is responsible for determining product strategy, development, execution, and implementation. He will help define Devana Solution’s product roadmap to deliver world-class experiences by driving innovation through data analysis and qualitative customer feedback.

“Alex epitomizes the expertise the Head of Product for a high-growth SaaS solutions provider like Devana Solutions requires going forward. As the point person from product strategy to go-to-market, there are few more qualified than Alex Schneider. He will be a great compliment to our outstanding leadership team,” says Devana Solutions CEO & Co-founder Barry Lake.

Devana Solutions is thrilled to have Alex join our team – we know he’ll help us do great things!

Devana Solutions Enhances Advisory Board with Addition of Velocity Clinical Research’s Craig Koch

[Chapel Hill, NC, March 17, 2022] Devana Solutions, the leading cloud SaaS provider to the clinical trials industry to connect centralized research professionals to staff and clinicians at decentralized site locations, announced today that industry veteran Craig Koch has joined Devana’s Advisory Board. Koch is currently Executive Vice President of Velocity Clinical Research, a leading integrated research organization in the U.S. with global expansion now underway. Koch will join current Syneos Health Senior Vice President Tom Wollman and longtime software investor and advisor Reid Conrad currently on Devana’s Advisory Board.

“I am delighted to have Craig join our Advisory Board,” stated Barry Lake, Devana Solutions’ CEO, “Velocity Clinical Research is perhaps the most optimized organization now leveraging our advanced PROPEL enterprise platform, and Craig’s analytical skills and leadership are a big reason why. I look forward to his contributions as an advisor to Devana Solutions, particularly with the transformative development initiatives Devana will be delivering to the industry in 2023.”

“Devana Solutions’ began as a tool for clinical research sites where it will remain the gold standard for research site productivity. The flexibility of the platform and the talent of the team also position Devana to be a Solution poised to unify what is a very disjointed industry.”

Founded in 2017, Velocity has grown dramatically in the last few years and now comprises 30 research sites across the United States with current global expansion underway. The Velocity model represents a new approach to site management. By owning and operating all sites directly, the organization offers a robust infrastructure that completely integrates the sites with singular systems and processes. Their model has proven to provide consistent and predictable patient recruitment and engagement. From a systems perspective, Velocity is an extremely technology-enabled organization, and under Koch’s direction, the Devana Solutions platform lies at the heart of Velocity’s business development, feasibility, and pre-award workflows, and both trial enrollment and overall business performance analytics.

According to Lake, “Craig’s expertise in leveraging our technology and industry insights will be a strong addition to Devana’s Advisory Board and our company. I look forward to his contributions.”

About Devana Solutions

Decentralized clinical trials and work-from-anywhere is now a reality. Devana Solutions’ innovative cloud platform supports real-time collaboration between central research operations professionals and decentralized clinicians serving patients in diverse communities. Devana even bridges the technology access and data divide by seamlessly and securely connecting decentralized researchers to other mission-critical clinical trials systems. From pipeline administration to rapid study startup automation. From document-sharing through the capture, display, analysis, and exchange of key trial performance metrics data from central research leaders to decentralized trial teams. From investigative site to CRO to trial sponsor, Devana Solutions is the answer. At Devana Solutions, we’re transforming the business of clinical trials.

About Velocity Clinical Research

Velocity Clinical Research, headquartered in Durham, NC, is the leading integrated site organization for clinical trials, offering dedicated site capabilities to help biopharmaceutical and contract research organization customers find the right patients for their studies. Velocity supports global drug development in primarily conducting phase II and phase III clinical trials. The company has 30 U.S. locations across 14 states. Velocity places the care of the patient at the heart of everything we do. With over 35 years of experience running sites and more than 7,000 studies completed, Velocity has refined its patient recruitment strategies while maintaining a focus on delivering timely and reliable data quality. For more information. visit our website at

Devana Solutions Connects Research Operations and Business Intelligence at Scale with Clinical Conductor Integration

A new interface between Devana’s IGNITE and PROPEL products and Advarra’s Cloud-Based Clinical Trial Management System establishes an end-to-end solution for efficient research conduct and world-class business intelligence.

CHAPEL HILL, NC (March 10, 2022)Devana Solutions is pleased to announce a new, at scale CTMS- integration solution for research organizations utilizing Advarra’s Clinical Conductor Clinical Trial Management System (CTMS), improving efficiency, and providing research sites with actionable insights across their entire research portfolio.

The Devana <-> Advarra integration is a dynamic, bi-directional data and process flow between Devana’s IGNITE and PROPEL products, and Advarra’s industry-leading Clinical Conductor CTMS. Following the natural progression of a trial, the trial startup begins in Devana, flows through Clinical Conductor for clinical execution and research operations management, and then back to Devana for end-to-end business intelligence. Enrollment performance metrics are derived automatically and pulled into the Devana system as research teams are interacting with Clinical Conductor, reducing duplicative workflows within the systems.

The robust and sought-after analytics, available within the Devana systems, offer configurable views to analyze performance data, by trial or indication, by site, or organization-wide. Combined with Clinical Conductor’s ability to optimize operational finances, regulatory compliance, and overall operational workflows, these integrated products provide a seamless, comprehensive, clinical research solution. After a very thorough and thoughtful technical approach, the Devana <-> Advarra CTMS integration is now live for all Clinical Conductor customers.

“At Devana Solutions, we have always prided ourselves in listening to our clients and being attentive to their needs,” explained Barry Lake, Devana Solutions’ CEO. “So, when the leadership at highly-valued client-partners, Javara Research and Velocity Clinical Research, encouraged an API-integration with Advarra’s Clinical Conductor CTMS to better support their study teams, we were eager to explore it.”

“We were pleased to work closely with the team at Advarra and the integration of both systems has increased our clients’ operational efficiency. We look forward to deploying the connection for the benefit of additional mutual clients. Working together, as an industry, we can and will move mountains!” added Lake.

“We are thrilled to collaborate with Devana and our customers on this innovative interface,” said James Wurdeman, Chief Product Officer at Advarra. “Devana’s approach to developing this integration aligns with our philosophy of creating site-centric, open, customer-focused technology solutions that can be integrated with enterprise systems across a research site or site network.”

Devana Solutions now boasts integrations with several leading CTMS technologies on the market. These integrations speak to more than just added convenience and increased efficiencies; they’re speeding up the clinical trial process resulting in improved clinical outcomes and therapies to patients.

About Devana Solutions

Decentralized clinical trials and work-from-anywhere is now a reality. Devana Solutions innovative cloud platform supports real-time collaboration between central research operations professionals and decentralized clinicians serving patients in diverse communities. Devana even bridges the technology access and data divide by seamlessly and securely connecting decentralized researchers to other mission-critical clinical trials systems. From pipeline administration to rapid study startup automation. From document-sharing through the capture, display, analysis, and exchange of key trial performance metrics data from central research leaders to decentralized trial teams. From investigative site to CRO to trial sponsor, Devana Solutions is the answer. At Devana Solutions, we’re transforming the business of clinical trials.

About Advarra

Advarra makes clinical research safer, smarter, and faster. Our integrated solutions help safeguard trial participants, empower clinical sites, ensure compliance, and optimize research performance for over 3,500 sponsors, CROs, institutions, academic medical centers, and research consortia.

With trusted and unequaled independent oversight committee services, innovative software solutions for sites, sponsors, and CROs, and experienced consultants with deep-seated connections across the industry, Advarra has the expertise and technology needed to advance clinical research and help our clients make the world a healthier place.

Headquartered in Columbia, Maryland, Advarra’s extensive geographic reach helps clients navigate the evolving research and regulatory environment.

Devana Solutions Announces Roxanne Shenefield as New Director, Solutions Services

Roxanne Shenefield

Devana Solutions is excited to announce Roxanne Shenefield as Devana’s Director, Solutions Services.  

Since May of 2019, our partner-clients have benefitted from Roxanne’s technological acumen and customer service during this time.  Roxanne truly lives our motto, Better Data, Better Decisions, Better Outcomes. Analytics are second nature to Roxanne, and her passion for data is unparalleled.

“I’ve always enjoyed the puzzle that surrounds a new technology – learning how it works, putting the pieces together, and continuing to build on it over time,” said Roxanne.

“Roxanne’s programming talent and strong communication skills are well-known to our partner-clients. She’s done an impressive job building out a solid team,” said Devana CEO and Co-founder Barry Lake.

In her new role, Roxanne will serve as the subject matter expert for the Devana Solutions suite of SaaS platform technologies in both customer-facing and internal roles.  

As part technical project manager, part administrator, and part analyst, Roxanne will be the conduit between business and technology. She will lead the development, customization, and integration efforts of solutions for our internal technology requirements.

“Roxanne’s ability to understand the strategic use of our Devana platform makes her the ideal choice to bridge our technological innovation and high growth SaaS business needs as Director, Solutions Services,” Barry added.  

Roxanne will also collaborate with Customer Success and Product Management to develop and implement new optimizations in the Devana Suite of products. She will also play a critical role in partner-client customizations and custom builds, and in future API integrations as Devana’s compatibility with other systems continues to grow.

Roxanne is ready to lead Devana’s future growth.  “I’m excited to be taking on this new challenge, focusing on expanding and scaling our technology solutions both internally and for our valued partner-clients,” she said.

“Roxanne has a history of demonstrating an insatiable curiosity for all things tech and data analytics. She continually demonstrates a mastery of understanding customer pain points and actively developing solutions,” said Devana Vice President of Operations, Linda Parks.

Whether you are a current partner-client or a future one of Devana Solutions, pretty much everything you encounter, from guides to videos and FAQs, will have Roxanne’s fingerprints on them.


Devana Solutions Welcomes Kirsten Zagarino as Director, Customer Success

Kirsten ZagarinoDevana Solutions is excited to welcome Kirsten Zagarino to the team as Devana’s Director, Customer Success.  

Kirsten has an accomplished history in the clinical research space with a multi-faceted background that will help lead Devana Solutions and drive partner-client growth and success.  She carries a passion for serving customers and collaborating with innovative teams.  

She said, “I am looking forward to working with the exceptional Devana Solutions team and helping them continue their track record of success with Partner-Clients and speed new therapies to patients.”

Devana Solutions CEO and Co-founder Barry Lake echoed this excitement:

“Kirsten’s hiring to lead our Customer Success Team is a direct reflection of the growth and success of our innovative cloud platform for the clinical trials industry. With most of the leading global site networks and integrated research organizations now partner-clients and major moves into health systems and CROs, sponsors this year, we welcome Kirsten’s expertise in scaling our client-facing staff.” 

Kirsten will be responsible for the strategic focus and operational oversight for the Customer Success department, where the priority is optimizing the use and adoption of Devana Solutions platforms.

Kirsten has shown mastery of many of these core responsibilities throughout her career.

In the last decade alone, Kirsten has led client adoption of Life Sciences SaaS products, including the implementation, onboarding and adoption experience. She has held such roles as analyst, software project manager, engagement manager, customer success manager in clinical technologies, and Associate Director Customer Success Shared Data and Profiles for the IQVIA Trial Design Group, where she has spent the last eight years of her career. 

Through her career, Kirsten had working relationships with 17 of the Top 20 Pharmaceutical Companies in the world. 

With Devana, Kirsten will be responsible for delivering an exceptional customer experience and maximizing customer value and retention.  This includes defining and overseeing the partner-client lifecycle process and touchpoints, including the following emphasis with the customer’s leadership team: process reviews, executive business reviews, action plans, roadmaps to drive value against their evolving business objectives. 

Internally, Kirsten will collaborate cross-functionally to advocate for the client-partner and lead the team to ensure that the Voice of the Customer is ingrained in Devana Solutions’ SaaS Suite and support strategies. This leadership centers around building an innate mission to drive value from our platform in support of the customers’ key business objectives.

And while the role is demanding, Barry is confident Kirsten will thrive. He added, “She’s a perfect fit, and we are thrilled to have her talent.”